Juha Rinne
 
| 
 jurin@utu.fi +358 50 441 2400 | 
- Progression of Amyloid Accumulation in Late Adulthood Among People With Childhood-Onset Epilepsy  (2025)  - Neurology
 
- Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study  (2025)  - EBioMedicine
 
- Synaptic Density in Multiple Sclerosis  (2025)  - Neurology, Neuroimmunology and Neuroinflammation
 
- The protective PLCγ2-P522R variant mitigates Alzheimer’s disease-associated pathologies by enhancing beneficial microglial functions  (2025)  - Journal of Neuroinflammation
 
- Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort  (2024)  - NeuroImage: Clinical
 
- Alzheimerin taudin lääkehoito  (2024)  Lääketieteellinen farmakologia ja toksikologia Rinne, Juha; Scheinin, Mika
- Alzheimerin tauti sairautena  (2024)  Lääketieteellinen farmakologia ja toksikologia Rinne, Juha; Scheinin, Mika
- Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial  (2024)  - Alzheimer's and Dementia
 
- Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial (Nature Medicine, (2023), 29, 6, (1437-1447), 10.1038/s41591-023-02326-3)  (2024)  - Nature Medicine
 
- Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly  (2024)  - Alzheimer's Research and Therapy
 
- Bone marrow metabolism is affected by body weight and response to exercise training varies according to anatomical location  (2024)  - Diabetes, Obesity and Metabolism
 
- Brain amyloid load, subjective memory complaints, and cognitive trajectories in older individuals at risk for dementia  (2024)  - European Journal of Neurology
 
- Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET  (2024)  - Neurobiology of Disease
 
- Correction to: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (EJNMMI Research, (2024), 14, 1, (25), 10.1186/s13550-024-01085-7)  (2024)  - EJNMMI Research
 
- Effects of Obesity and Exercise on Hepatic and Pancreatic Lipid Content and Glucose Metabolism : PET Studies in Twins Discordant for BMI  (2024)  - Biomolecules
 
- Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes  (2024)  - Alzheimer's and Dementia
 
- Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA  (2024)  - EJNMMI Research
 
- Kinetic Modeling of Brain [18-F]FDG Positron Emission Tomography Time Activity Curves with Input Function Recovery (IR) Method  (2024)  - Metabolites
 
- Measurement invariance of the Center for Epidemiological Studies-Depression scale and associations with genetic risk in older adults  (2024)  - PLoS ONE
 
- Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation : A 5-year follow-up [11C]PIB-PET study  (2024)  - Neurobiology of Disease
 




